Cantel Subsidiary Receives Expanded EPA Approval for Minncare Cold Sterilant in Fogging Applications
LITTLE FALLS, N.J. Cantel Medical Corp. announced today that its subsidiary, Minntech Corporation, has received expanded approval from the United States Environmental Protection Agency (EPA) for the use of its Minncare® Cold Sterilant in fogging applications.
Minncare® Cold Sterilant, in its liquid form, is widely used to disinfect ultrapure water production and distribution systems in critical applications such as kidney dialysis centers, pharmaceutical manufacturing and the micro-electronics industries.
Roy K Malkin, president and CEO of Minntech, noted: The expanded EPA approval covers applications of key concentrations and droplet sizes that will allow our U.S. customers to use Minncare® Cold Sterilant in a much wider range of fogging applications. Our experience and testing in Europe and Japan have shown that the use of Minncare® Cold Sterilant in a dry fog state at specific combinations of concentration and droplet size can provide significant benefits over aldehyde-based fogging systems. In particular, Minncare fogging applications in biotechnology and pharmaceutical manufacturing clean rooms are quite rapid and can minimize down time of manufacturing equipment.
He continued, Today, the contamination of surfaces with airborne pathogens has become an area of increasing concern, and we believe that the utilization of Minncare® Cold Sterilant, in its dry fog state, provides a safe and effective alternative for a variety of applications.
Cantel Medical Corp., a healthcare company, is a leading provider of infection prevention and control products, specialized medical device reprocessing systems, water treatment systems, sterilants, specialty packaging for shipping infectious and biological substances, diagnostic imaging and therapeutic medical equipment primarily focused on endoscopy, hollow fiber membrane filtration and separation technologies for medical and non-medical applications, and scientific instrumentation.
Source: Cantel Medical Corp.
Ensuring Safety and Comfort: The Urgent Need for Well-Fitted PPE in Health Care
April 5th 2024Personal protective equipment (PPE) stands as the first line of defense against infectious diseases in health care. Yet, the issue of ill-fitting PPE, especially for women, remains a significant challenge.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
